1. Home
  2. FORTY vs NVAX Comparison

FORTY vs NVAX Comparison

Compare FORTY & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORTY
  • NVAX
  • Stock Information
  • Founded
  • FORTY 1985
  • NVAX 1987
  • Country
  • FORTY Israel
  • NVAX United States
  • Employees
  • FORTY N/A
  • NVAX N/A
  • Industry
  • FORTY EDP Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FORTY Technology
  • NVAX Health Care
  • Exchange
  • FORTY Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • FORTY 1.4B
  • NVAX 1.3B
  • IPO Year
  • FORTY 1997
  • NVAX 1995
  • Fundamental
  • Price
  • FORTY $99.77
  • NVAX $7.99
  • Analyst Decision
  • FORTY
  • NVAX Buy
  • Analyst Count
  • FORTY 0
  • NVAX 6
  • Target Price
  • FORTY N/A
  • NVAX $17.83
  • AVG Volume (30 Days)
  • FORTY 1.0K
  • NVAX 3.6M
  • Earning Date
  • FORTY 03-18-2025
  • NVAX 02-27-2025
  • Dividend Yield
  • FORTY 1.26%
  • NVAX N/A
  • EPS Growth
  • FORTY 18.72
  • NVAX N/A
  • EPS
  • FORTY 4.83
  • NVAX N/A
  • Revenue
  • FORTY $2,706,303,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • FORTY N/A
  • NVAX N/A
  • Revenue Next Year
  • FORTY N/A
  • NVAX N/A
  • P/E Ratio
  • FORTY $20.17
  • NVAX N/A
  • Revenue Growth
  • FORTY 2.60
  • NVAX N/A
  • 52 Week Low
  • FORTY $69.07
  • NVAX $3.81
  • 52 Week High
  • FORTY $100.00
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • FORTY 67.12
  • NVAX 42.04
  • Support Level
  • FORTY $99.43
  • NVAX $7.70
  • Resistance Level
  • FORTY $100.00
  • NVAX $8.54
  • Average True Range (ATR)
  • FORTY 0.82
  • NVAX 0.39
  • MACD
  • FORTY 0.47
  • NVAX -0.04
  • Stochastic Oscillator
  • FORTY 97.70
  • NVAX 23.58

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: